232 related articles for article (PubMed ID: 21463108)
1. Mechanism of action of pentostatin and cladribine in hairy cell leukemia.
Johnston JB
Leuk Lymphoma; 2011 Jun; 52 Suppl 2():43-5. PubMed ID: 21463108
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of deoxyadenosine and 2-chlorodeoxyadenosine toxicity to nondividing human lymphocytes.
Seto S; Carrera CJ; Kubota M; Wasson DB; Carson DA
J Clin Invest; 1985 Feb; 75(2):377-83. PubMed ID: 2579098
[TBL] [Abstract][Full Text] [Related]
3. 2-Chloro-2'-deoxyadenosine (2CdA) biochemical aspects of antileukemic efficacy.
Fabianowska-Majewska K; Wyczechowska D
Acta Pol Pharm; 1996; 53(4):231-9. PubMed ID: 9415193
[TBL] [Abstract][Full Text] [Related]
4. [Hairy cell leukemia and its treatment with 2-chlorodeoxyadenosine (2-CdA)].
Pawelski S
Acta Haematol Pol; 1995; 26(2):139-43. PubMed ID: 7653218
[TBL] [Abstract][Full Text] [Related]
5. Enzyme activities of leukemic cells and biochemical changes induced by deoxycoformycin in vitro--lack of correlation with clinical response.
Ho AD; Ganeshaguru K; Knauf W; Dietz G; Trede I; Hoffbrand AV; Hunstein W
Leuk Res; 1989; 13(4):269-78. PubMed ID: 2785618
[TBL] [Abstract][Full Text] [Related]
6. [Hairy cell leukemia--a potentially curable malignancy. Selected aspects of purine analog therapy].
Rucińska M; Machaczka M; Załuska A; Skotnicki AB
Przegl Lek; 1998; 55(7-8):400-6. PubMed ID: 10021885
[TBL] [Abstract][Full Text] [Related]
7. Purine nucleoside analogs as immunosuppressive and antineoplastic agents: mechanism of action and clinical activity.
Robak T; Lech-Maranda E; Korycka A; Robak E
Curr Med Chem; 2006; 13(26):3165-89. PubMed ID: 17168705
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of DNA repair by deoxyadenosine in resting human lymphocytes.
Seto S; Carrera CJ; Wasson DB; Carson DA
J Immunol; 1986 Apr; 136(8):2839-43. PubMed ID: 2870121
[TBL] [Abstract][Full Text] [Related]
9. [Cladribine].
Ogura M
Gan To Kagaku Ryoho; 2003 Feb; 30(2):309-17. PubMed ID: 12610885
[TBL] [Abstract][Full Text] [Related]
10. Clinical response to deoxycoformycin in chronic lymphoid neoplasms and biochemical changes in circulating malignant cells in vivo.
Ho AD; Ganeshaguru K; Knauf WU; Dietz G; Trede I; Hunstein W; Hoffbrand AV
Blood; 1988 Dec; 72(6):1884-90. PubMed ID: 3264192
[TBL] [Abstract][Full Text] [Related]
11. Complete remissions in hairy cell leukemia with 2-chlorodeoxyadenosine after failure with 2'-deoxycoformycin.
Saven A; Piro LD
Ann Intern Med; 1993 Aug; 119(4):278-83. PubMed ID: 8101069
[TBL] [Abstract][Full Text] [Related]
12. Induction of apoptosis in vivo and in vitro in hairy cell leukemia treated by deoxycoformycin.
Ogawa K; Shichishima T; Nakamura N; Maruyama Y
Tohoku J Exp Med; 2000 Sep; 192(1):87-98. PubMed ID: 11128872
[TBL] [Abstract][Full Text] [Related]
13. Minimal residual disease in patients with hairy cell leukemia in complete remission treated with 2-chlorodeoxyadenosine or 2-deoxycoformycin and prediction of early relapse.
Tallman MS; Hakimian D; Kopecky KJ; Wheaton S; Wollins E; Foucar K; Cassileth PA; Habermann T; Grever M; Rowe JM; Peterson LC
Clin Cancer Res; 1999 Jul; 5(7):1665-70. PubMed ID: 10430066
[TBL] [Abstract][Full Text] [Related]
14. Treatment of hairy-cell leukemia: current views.
Tallman MS; Peterson LC; Hakimian D; Gillis S; Polliack A
Semin Hematol; 1999 Apr; 36(2):155-63. PubMed ID: 10319384
[TBL] [Abstract][Full Text] [Related]
15. Relationship between cladribine (CdA) plasma, intracellular CdA-5'-triphosphate (CdATP) concentration, deoxycytidine kinase (dCK), and chemotherapeutic activity in chronic lymphocytic leukemia (CLL).
Albertioni F; Lindemalm S; Eriksson S; Juliusson G; Liliemark J
Adv Exp Med Biol; 1998; 431():693-7. PubMed ID: 9598154
[TBL] [Abstract][Full Text] [Related]
16. [Clinical pharmacology of 2-chlorodeoxyadenosine (Cladribine)].
Góra-Tybor J; Robak T
Przegl Lek; 1996; 53(8):614-8. PubMed ID: 8999463
[TBL] [Abstract][Full Text] [Related]
17. Resistance of leukemic cells to 2-chlorodeoxyadenosine is due to a lack of calcium-dependent cytochrome c release.
Chandra J; Mansson E; Gogvadze V; Kaufmann SH; Albertioni F; Orrenius S
Blood; 2002 Jan; 99(2):655-63. PubMed ID: 11781251
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment of patients with hairy cell leukemia (HCL) using a single cycle of 2-chloro-2'-deoxyadenosine (CdA).
Jehn U; Gawaz M; Grunewald R; Hill W; Lorenz B; Stôtzer O
Anticancer Res; 1993; 13(5C):1809-14. PubMed ID: 7903521
[TBL] [Abstract][Full Text] [Related]
19. Profound toxicity of deoxyadenosine and 2-chlorodeoxyadenosine toward human monocytes in vitro and in vivo.
Carrera CJ; Yamanaka H; Piro LD; Lotz M; Carson DA
Adv Exp Med Biol; 1989; 253B():219-25. PubMed ID: 2575348
[TBL] [Abstract][Full Text] [Related]
20. On the phosphorylation of 2-chlorodeoxyadenosine (CdA) and its correlation with clinical response in leukemia treatment.
Arnér ES
Leuk Lymphoma; 1996 Apr; 21(3-4):225-31. PubMed ID: 8726403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]